A drug on the market?

This publication has 21 references indexed in Scilit:

• New drug development in the United States from 1963 to 1992
  Clinical Pharmacology & Therapeutics, 1994
• Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population
  Diabetologia, 1993
• Islet amyloid: An enigma of type 2 diabetes
  Diabetes/Metabolism Research and Reviews, 1992
• Biopharmaceuticals and Conventional Drugs: Clinical Success Rates
  Nature Biotechnology, 1992
• Newly Identified Pancreatic Protein Islet Amyloid Polypeptide: What Is Its Relationship to Diabetes?
  Diabetes, 1991
• Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.
  Proceedings of the National Academy of Sciences, 1987
• ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES
  The Lancet, 1987
• Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.
  Proceedings of the National Academy of Sciences, 1987
• A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas
  Biochemical and Biophysical Research Communications, 1986
• THE RELATION OE DIABETES MELLITUS TO LESIONS OF THE PANCREAS. HYALINE DEGENERATION OF THE ISLANDS OE LANGERHANS
  The Journal of Experimental Medicine, 1901